CELU vs VRTX: Which Stock is Better?
Side-by-side comparison of Celularity Inc and Vertex Pharmaceuticals Inc in 2026
CELU
Celularity Inc
$1.23
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | CELU | VRTX | Winner |
|---|---|---|---|
| Market Cap | $35.76M | $110.81B | VRTX |
| P/E Ratio | N/A | 28.42 | VRTX |
| EPS (TTM) | $N/A | $15.33 | VRTX |
| Revenue Growth | -0.4% | 0.1% | VRTX |
| Gross Margin | 50.6% | 53.7% | VRTX |
Analyze CELU
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELU or VRTX a better investment?
Comparing CELU and VRTX: Celularity Inc has a market cap of $35.76M while Vertex Pharmaceuticals Inc has $110.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELU and VRTX?
CELU (Celularity Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELU or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELU or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.4% for CELU.
Which company is more profitable: CELU or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 50.6% for CELU.
Which is the larger company: CELU or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.81B compared to $35.76M for CELU.
Should I buy CELU or VRTX in 2026?
Both CELU and VRTX have investment merit. CELU trades at $1.23 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELU and VRTX stock?
Key differences: Market Cap ($35.76M vs $110.81B), P/E Ratio (N/A vs 28.4x), Revenue Growth (-0.4% vs 0.1%), Gross Margin (50.6% vs 53.7%).